By Frank Prenesti
Date: Wednesday 17 Sep 2025
(Sharecast News) - GSK has announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years, amid fears of tariffs being imposed on the pharma industry by US President Donald Trump, who is in the UK on a state visit.
Holding(s) in Company | 17-Sep-2025 | 18:15 | RNS |
Holding(s) in Company | 17-Sep-2025 | 18:14 | RNS |
Form 8.3 - Spirent Communications plc | 17-Sep-2025 | 15:25 | Business Wire |
Form 8.3 - Spirent Communications plc | 17-Sep-2025 | 15:25 | Business Wire |
Form 8.3 - Spectris plc | 17-Sep-2025 | 15:25 | Business Wire |
Questor:Meggitt | 23-Dec-2014 | Telegraph |
Questor :KCOM | 27-Nov-2014 | Telegraph |
Questor :Ricardo | 31-Oct-2014 | Telegraph |
Questor:CSR | 17-Oct-2014 | Telegraph |
Questor:BAE Systems | 03-Sep-2014 | Telegraph |
Price | 5,384.07 |
Change Today | 12.91 |
% Change | 0.24 % |
17-Sep-25 Close | 5,384.07 |
You are here: research